# Vaccines for Adults FY26-27

Canonical: https://abierto.us/opportunities/75d30126r73406

- Solicitation number: 75D30126R73406
- Notice type: Combined synopsis and solicitation
- Status: Awarded to Bavarian Nordic, Inc.
- Department: Department of Health and Human Services
- Agency: Centers for Disease Control and Prevention
- Contracting office: CDC Office of Acquisition Services (75D301)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- Place of performance: Atlanta, Georgia
- County: DeKalb County (FIPS 13089). https://abierto.us/counties/dekalb-county-ga-13089
- City: Atlanta. https://abierto.us/cities/atlanta-ga-1304000
- First posted: March 24, 2026
- Last posted: March 24, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/6921f2f425874329b78966070aba672b/view

## Description

The Centers for Disease Control and Prevention (CDC) contemplates award of one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the purchase of standard commercial adult vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The establishment of these contracts provides opportunity to utilize Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace.

These funds provide vaccines for state and local health departments to use in populations at greatest risk for under vaccination and disease. The 317 program, as established under Section 317(j) of the Public Health Service Act, works to ensure that adults receive appropriate immunization by partnering with healthcare providers in the public and private sectors. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage.

The vaccines awarded under these contracts will be purchased for the National Center for Immunization and Respiratory Disease’s (NCIRD’s) immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. In addition, awardees may opt to purchase additional quantities of vaccine for adults under any resulting contract using state and local funds.

## Award on USAspending

- Recipient: Bavarian Nordic, Inc. (UEI LA6TFGKSSFC1)
- Contract: 75D30126D20934
- Obligated: $169,038.46
- Competition: Full and Open Competition, 6 offers received
- Link: solicitation number 75D30126R73406 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20934_7523/

- Recipient: Glaxosmithkline, LLC (UEI FRHTPHMZMX47)
- Contract: 75D30126D20935
- Obligated: $10,371,737.66
- Competition: Full and Open Competition, 6 offers received
- Link: solicitation number 75D30126R73406 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20935_7523/

- Recipient: Merck Sharp & Dohme LLC (UEI FCFDA78HKKG2)
- Contract: 75D30126D20936
- Obligated: $7,233,463.02
- Competition: Full and Open Competition, 6 offers received
- Link: solicitation number 75D30126R73406 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20936_7523/

- Recipient: Moderna Us, Inc. (UEI G5BFKCJLDML6)
- Contract: 75D30126D20937
- Obligated: $29,837.26
- Competition: Full and Open Competition, 6 offers received
- Link: solicitation number 75D30126R73406 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20937_7523/

- Recipient: Pfizer Inc. (UEI MHBQULRMEEJ5)
- Contract: 75D30126D20938
- Obligated: $2,668,855.40
- Competition: Full and Open Competition, 6 offers received
- Link: solicitation number 75D30126R73406 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20938_7523/

- Recipient: Sanofi Vaccines US Inc. (UEI NCXBGGQ8YTU9)
- Contract: 75D30126D20939
- Obligated: $3,530,679.12
- Competition: Full and Open Competition, 6 offers received
- Link: solicitation number 75D30126R73406 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30126D20939_7523/


## Publications

- March 24, 2026: Combined synopsis and solicitation, due April 7, 2026 at 1:00 PM EDT. Notice 6921f2f425874329b78966070aba672b. https://sam.gov/workspace/contract/opp/6921f2f425874329b78966070aba672b/view

## Points of contact

- James Sprigler, zbs6@cdc.gov
- Chad Turner, ukr9@cdc.gov

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75d30126r73406.
